Meeting of the Presidential Advisory Council on HIV/AIDS, 34166 [2023-11250]
Download as PDF
34166
Federal Register / Vol. 88, No. 102 / Friday, May 26, 2023 / Notices
collections of information are subject to
review by OMB under the PRA. The
collections of information in 21 CFR
part 312 have been approved under
OMB control number 0910–0014.
DATES:
III. Electronic Access
Persons with access to the internet
may obtain the draft guidance at https://
www.fda.gov/drugs/guidancecompliance-regulatory-information/
guidances-drugs, https://www.fda.gov/
regulatory-information/search-fdaguidance-documents, or https://
www.regulations.gov.
ADDRESSES:
Dated: May 23, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–11321 Filed 5–25–23; 8:45 am]
The meeting will be held on
Wednesday, June 28 from
approximately 12 p.m.–9 p.m. (ET) and
Thursday, March 29 from approximately
12 p.m.–6 p.m. (ET).
The meeting will be located
at the Kimpton Hotel, Palomar Phoenix
located at 2 East Jefferson Street,
Phoenix, AZ 85004. To attend the
meeting virtually, please visit
www.hhs.gov/live.
Ms.
Caroline Talev, MPA, Senior
Management Analyst, at PACHA@
hhs.gov or Caroline.Talev@hhs.gov.
Additional information can be obtained
by accessing the Council’s page on the
HIV.gov site at www.hiv.gov/pacha.
FOR FURTHER INFORMATION CONTACT:
BILLING CODE 4164–01–P
PACHA
was established by Executive Order
12963, dated June 14, 1995, as amended
by Executive Order 13009, dated June
14, 1996 and is currently operating
under the authority given in Executive
Order 14048, dated September 30, 2021.
The Council was established to provide
advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to promote effective HIV
diagnosis, treatment, prevention, and
quality care services. The functions of
the Council are solely advisory in
nature. The Council consists of not more
than 35 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
population health, philanthropy,
marketing or business, as well as other
national leaders held in high esteem
from other sectors of society. PACHA
selections also include persons with
lived HIV experience and racial/ethnic
and sexual and gender minority persons
disproportionately affected by HIV.
Council members are appointed by the
Secretary.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
ACTION: Notice of a hybrid meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Service is hereby giving notice that the
Presidential Advisory Council on HIV/
AIDS (PACHA or the Council) will
convene the 77th full council meeting
on Wednesday, June 28 and Thursday
June 29, 2023. The meeting will
convene in Phoenix, Arizona and it will
also utilize virtual technologies. The
meeting will be open to the public. Due
to limited space, pre-registration is
encouraged for members of the public
who wish to attend the meeting inperson. Please email your name to
PACHA@hhs.gov by close of business
Tuesday, June 20, 2023 to pre-reigster.
There will be a public comment session
during the meeting; pre-registration is
required to provide public comment. To
pre-register to provide public comment,
please send an email to PACHA@
hhs.gov and include your name,
organization, and title by close of
business June 20, 2023. If you decide
you would like to provide public
comment but do not pre-register, you
may submit your written statement by
emailing PACHA@hhs.gov by close of
business July 12, 2023. The meeting
agenda will be posted on the PACHA
page on HIV.gov at https://www.hiv.gov/
federal-response/pacha/about-pacha
prior to the meeting.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:14 May 25, 2023
Jkt 259001
Dated: May 17, 2023.
Caroline Talev,
Senior Management Analyst, Office of
Infectious Disease and HIV/AIDS Policy,
Alternate Designated Federal Official,
Presidential Advisory Council on HIV/AIDS,
Office of the Assistant Secretary for Health,
Department of Health and Human Services.
[FR Doc. 2023–11250 Filed 5–25–23; 8:45 am]
National Institutes of Health
Office of the Secretary; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Interagency Pain
Research Coordinating Committee.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The meeting can be accessed
from the NIH Videocast at the following
link: https://videocast.nih.gov/.
Name of Committee: Interagency Pain
Research Coordinating Committee (IPRCC).
Date: June 23, 2023.
Time: 11:00 a.m. to 12:30 p.m. Eastern
Time (ET).
Agenda: The meeting will cover committee
business items and IPRCC member updates.
Items discussed will include updates on the
Helping to End Addiction Long-Term (HEAL)
Initiative and the Federal Pain Research
Strategy (FPRS) research progress, and an
update from the Centers for Medicare and
Medicaid Services (CMS).
Deadline: Submission of intent to submit
written/electronic statement for comments:
Friday, June 16 by 5:00 p.m. ET.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Linda L. Porter, Ph.D.,
Director, Office of Pain Policy, and Planning,
Office of the Director, National Institute of
Neurological Disorders and Stroke, NIH, 31
Center Drive, Room 8A31, Bethesda, MD
20892.
Phone: (301) 451–4460.
Email: Linda.Porter@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
The meeting will be open to the public via
NIH Videocast https://videocast.nih.gov/.
Visit the IPRCC website for more
information: https://iprcc.nih.gov. Agenda and
any additional information for the meeting
will be posted when available.
Dated: May 22, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4150–43–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–11230 Filed 5–25–23; 8:45 am]
BILLING CODE 4140–01–P
Frm 00041
Fmt 4703
Sfmt 9990
E:\FR\FM\26MYN1.SGM
26MYN1
Agencies
[Federal Register Volume 88, Number 102 (Friday, May 26, 2023)]
[Notices]
[Page 34166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11250]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Presidential Advisory Council on HIV/AIDS
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health.
ACTION: Notice of a hybrid meeting.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Service is hereby giving notice that the
Presidential Advisory Council on HIV/AIDS (PACHA or the Council) will
convene the 77th full council meeting on Wednesday, June 28 and
Thursday June 29, 2023. The meeting will convene in Phoenix, Arizona
and it will also utilize virtual technologies. The meeting will be open
to the public. Due to limited space, pre-registration is encouraged for
members of the public who wish to attend the meeting in-person. Please
email your name to [email protected] by close of business Tuesday, June 20,
2023 to pre-reigster. There will be a public comment session during the
meeting; pre-registration is required to provide public comment. To
pre-register to provide public comment, please send an email to
[email protected] and include your name, organization, and title by close
of business June 20, 2023. If you decide you would like to provide
public comment but do not pre-register, you may submit your written
statement by emailing [email protected] by close of business July 12, 2023.
The meeting agenda will be posted on the PACHA page on HIV.gov at
https://www.hiv.gov/federal-response/pacha/about-pacha prior to the
meeting.
DATES: The meeting will be held on Wednesday, June 28 from
approximately 12 p.m.-9 p.m. (ET) and Thursday, March 29 from
approximately 12 p.m.-6 p.m. (ET).
ADDRESSES: The meeting will be located at the Kimpton Hotel, Palomar
Phoenix located at 2 East Jefferson Street, Phoenix, AZ 85004. To
attend the meeting virtually, please visit www.hhs.gov/live.
FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, MPA, Senior
Management Analyst, at [email protected] or [email protected].
Additional information can be obtained by accessing the Council's page
on the HIV.gov site at www.hiv.gov/pacha.
SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order
12963, dated June 14, 1995, as amended by Executive Order 13009, dated
June 14, 1996 and is currently operating under the authority given in
Executive Order 14048, dated September 30, 2021. The Council was
established to provide advice, information, and recommendations to the
Secretary regarding programs and policies intended to promote effective
HIV diagnosis, treatment, prevention, and quality care services. The
functions of the Council are solely advisory in nature. The Council
consists of not more than 35 members. Council members are selected from
prominent community leaders with particular expertise in, or knowledge
of, matters concerning HIV and AIDS, public health, global health,
population health, philanthropy, marketing or business, as well as
other national leaders held in high esteem from other sectors of
society. PACHA selections also include persons with lived HIV
experience and racial/ethnic and sexual and gender minority persons
disproportionately affected by HIV. Council members are appointed by
the Secretary.
Dated: May 17, 2023.
Caroline Talev,
Senior Management Analyst, Office of Infectious Disease and HIV/AIDS
Policy, Alternate Designated Federal Official, Presidential Advisory
Council on HIV/AIDS, Office of the Assistant Secretary for Health,
Department of Health and Human Services.
[FR Doc. 2023-11250 Filed 5-25-23; 8:45 am]
BILLING CODE 4150-43-P